H. PYLORI ULCERS SHOULD RECEIVE DOUBLE/TRIPLE ANTIMICROBIAL THERAPY, NIH CONSENSUS PANEL CONCLUDES; BACTERIUM LINK TO GASTRIC CANCER NEEDS MORE STUDY
Executive Summary
Patients with peptic ulcers infected with the Helicobacter pylori bacterium should be treated with double or triple antimicrobial therapy, a National Institutes of Health consensus panel recommended Feb. 9.